Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbas, U. L., Anderson, R. M., & Mellors, J. W. (2007). Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS ONE, 2(9), e875.
Alliance for Microbicide Development (2006). Microbicide research and development database. (Accessed December 31, 2006); www.microbicide.org/cs/microbicide_rd_database.
Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., & Puren, A. (2005). Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Medicine, 2(11), e298.
Bailey, R. C., Moses, S., Parker, C. B., Agot, K., Maclean, I., Krieger, J. N., Williams, C. F., Campbell, R. T., & Ndinya-Achola, J. O. (2007). Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet, 369(9562), 643–656.
Barnhart, K. T., Pretorius, E. S., Timbers, K., Shera, D., Shabbout, M., & Malamud, D. (2004). In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse. Contraception, 70(6), 498–505.
Blower, S., Bodine, E., Kahn, J., & McFarland, W. (2005). The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS, 19(1), 1–14.
Coplan, P. M., Mitchnick, M., & Rosenberg, Z. F. (2004). Public health. Regulatory challenges in microbicide development. Science, 304(5679), 1911–1912.
Corey, L., Wald, A., Celum, C. L., & Quinn, T. C. (2004). The effects of Herpes Simplex Virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. Journal of Acquired Immune Deficiency Syndromes, 35(5), 435–445.
Cunningham, C. K., Chaix, M. L., Rekacewicz, C., Britto, P., Rouzioux, C., Gelber, R. D., Dorenbaum, A., Delfraissy, J. F., Bazin, B., Mofenson, L., & Sullivan, J. L. (2002). Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316. The Journal of Infectious Diseases, 186(2), 181–188.
D'Cruz, O. J. & Uckun, F. M. (2004). Clinical development of microbicides for the prevention of HIV infection. Current Pharmaceutical Design, 10(3), 315–336.
Duerr, A., Wasserheit, J. N., & Corey, L. (2006). HIV vaccines: new frontiers in vaccine development. Clinical Infectious Diseases, 43(4), 500–511.
Eshleman, S. H. & Jackson, J. B. (2002). Nevirapine resistance after single dose prophylaxis. AIDS Reviews, 4(2), 59–63.
Fauci, A. S. (2006). Twenty-five years of HIV/AIDS. Science, 313(5786), 409.
Garg, S., Kandarapu, R., Vermani, K., Tambwekar, K. R., Garg, A., Waller, D. P., & Zaneveld, L. J. (2003). Development pharmaceutics of microbicide formulations. Part I: preformulation considerations and challenges. AIDS Patient Care and STDs, 17(1), 17–32.
Garg, S., Tambwekar, K. R., Vermani, K., Kandarapu, R., Garg, A., Waller, D. P., & Zaneveld, L. J. (2003). Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challenges. AIDS Patient Care and STDs, 17(8), 377–399.
Grant, R. M., Buchbinder, S., Cates, W., Jr., Clarke, E., Coates, T., Cohen, M. S., Delaney, M., Flores, G., Goicochea, P., Gonsalves, G., Harrington, M., Lama, J. R., MacQueen, K. M., Moore, J. P., Peterson, L., Sanchez, J., Thompson, M., & Wainberg, M. A. (2005). AIDS. Promote HIV chemoprophylaxis research, don't prevent it. Science, 309(5744), 2170–2171.
Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chaudhary, M. A., Chen, M. Z., Sewankambo, N. K., Wabwire-Mangen, F., Bacon, M. C., Williams, C. F., Opendi, P., Reynolds, S. J., Laeyendecker, O., Quinn, T. C., & Wawer, M. J. (2007). Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet, 369(9562), 657–666.
Haghighi, D. B. & Lashner, B. A. (2004). Left-sided ulcerative colitis. Gastroenterology Clinics of North America, 33(2), 271–84, ix.
Hillier, S. L., Moench, T., Shattock, R., Black, R., Reichelderfer, P., & Veronese, F. (2005). In vitro and in vivo: The Story of Nonoxynol 9. Journal of Acquired Immune Deficiency Syndromes, 39(1), 1–8.
Hu, J., Gardner, M. B., & Miller, C. J. (2000). Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. Journal of Virology, 74(13), 6087–6095.
Kim, H. N., Tabet, S. R., Corey, L., & Celum, C. L. (2005). Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert. Vaccine, 24(3), 532–9.
Koblin, B., Chesney, M., Coates, T., & EXPLORE Study Team. (2004). Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet, 364(9428), 41–50.
Lard-Whiteford, S. L., Matecka, D., O'Rear, J. J., Yuen, I.S., Litterst, C., Reichelderfer, P., & International Working Group on Microbicides. (2004). Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update. Journal of Acquired Immune Deficiency Syndromes, 36(1), 541–552.
Mantell, J. E., Myer, L., Carballo-Dieguez, A., Stein, Z., Ramjee, G., Morar, N. S., & Harrison, P. F. (2005). Microbicide acceptability research: current approaches and future directions. Social Science & Medicine, 60(2), 319–330.
Mauck, C., Rosenberg, Z., & Van Damme, L. (2001). Recommendations for the clinical development of topical microbicides: an update. AIDS, 15(7), 857–868.
Mills, E., Rachlis, B., Wu, P., Wong, E., Wilson, K., & Singh, S. (2005). Media reporting of tenofovir trials in Cambodia and Cameroon. BMC International Health & Human Rights, 5, 6.
Neurath, A. R., Strick, N., & Li, Y. Y. (2003). Water dispersible microbicidal cellulose acetate phthalate film. BMC Infectious Diseases, 3, 27.
Owen, D. H., Peters, J. J., & Katz, D. F. (2000). Rheological properties of contraceptive gels. Contraception, 62(6), 321–326.
Padian, N. S., van der, Straten A., Ramjee, G., Chipato, T., de, Bruyn G., Blanchard, K., Shiboski, S., Montgomery, E. T., Fancher, H., Cheng, H., Rosenblum, M., van der, Laan M., Jewell, N., & McIntyre, J. (2007). Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet, 370(9583), 251–261.
Poles, M. A., Elliott, J., Taing, P., Anton, P. A., & Chen, I. S. (2001). A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. Journal of Virology, 75(18), 8390–8399.
Pretorius, A., Timbers, K., Malamud, D., & Barnhart, K. (2003). Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse. Contraception, 66(6), 443–451.
Ramjee, G., Govinden, R., Morar, N. S., & Mbewu, A. (2007). South Africa's experience of the closure of the cellulose sulphate microbicide trial. PLoS Medicine, 4(7), e235.
Sawires, S. R., Dworkin, S. L., Fiamma, A., Peacock, D., Szekeres, G., & Coates, T. J. (2007). Male circumcision and HIV/AIDS: challenges and opportunities. Lancet, 369(9562), 708–713.
Severy, L. J., Tolley, E., Woodsong, C., & Guest, G. (2005). A framework for examining the sustained acceptability of microbicides. AIDS and Behavior, 9(1), 121–131.
Sexton, A., Drake, P. M., Mahmood, N., Harman, S. J., Shattock, R. J., & Ma, J. K. (2006). Transgenic plant production of Cyanovirin-N, an HIV microbicide. FASEB Journal, 20(2), 356–358.
Shattock, R. J. (2006). Protection of macaques against rectal SIV challenge by mucosally-applied PMPA. Presented at Microbicides 2006, Cape Town, South Africa (Abstract OA15).
Shattock, R. J. & Moore, J. P. (2003). Inhibiting sexual transmission of HIV-1 infection. Nature Reviews. Microbiology, 1(1), 25–34.
Stein, Z. A. (1990). HIV prevention: the need for methods women can use. American Journal of Public Health, 80(4), 460–462.
Tsai, C. C., Emau, P., Jiang, Y., Tian, B., Morton, W. R., Gustafson, K. R., & Boyd, M. R. (2003). Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques. AIDS Research and Human Retroviruses, 19(7), 535–541.
UNAIDS. (2006). 2006 Report on the global AIDS epidemic. Geneva. www.unaids.org:80/en/KnowledgeCentre/HIVData/GlobalReport/Default.asp.
US Food and Drug Administration. (2006). Additional resources regarding drug development of topical microbicides. (Accessed December 31, 2006); www.fda.gov/cder/ode4/preind/Top_Links.htm.
Van Damme, L., Ramjee, G., Alary, M., Vuylsteke, B., Chandeying, V., Rees, H., Sirivongrangson, P., Mukenge-Tshibaka, L., Ettiegne-Traore, V., Uaheowitchai, C., Karim, S. S., Masse, B., Perriens, J., & Laga, M. (2002). Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet, 360(9338), 971–977.
Veazey, R. S., Klasse, P. J., Schader, S. M., Hu, Q., Ketas, T. J., Lu, M., Marx, P. A., Dufour, J., Colonno, R. J., Shattock, R. J., Springer, M. S., & Moore, J. P. (2005). Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature, 438(7064), 99–102.
Woolfson, A. D., Malcolm, R. K., Morrow, R. J., Toner, C. F., & McCullagh, S. D. (2006). Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. International Journal of Pharmaceutics, 325(1–2), 82–89.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer ScienceBusiness Media, LLC
About this chapter
Cite this chapter
McGowan, I. (2008). Microbicide Development. In: Celentano, D.D., Beyrer, C. (eds) Public Health Aspects of HIV/AIDS in Low and Middle Income Countries. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72711-0_6
Download citation
DOI: https://doi.org/10.1007/978-0-387-72711-0_6
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72710-3
Online ISBN: 978-0-387-72711-0
eBook Packages: MedicineMedicine (R0)